9,343 Shares in USANA Health Sciences, Inc. $USNA Acquired by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. acquired a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA) in the 2nd quarter, Holdings Channel.com reports. The fund acquired 9,343 shares of the company’s stock, valued at approximately $285,000.

Several other institutional investors have also recently modified their holdings of the stock. Ethic Inc. acquired a new position in shares of USANA Health Sciences during the 2nd quarter worth approximately $287,000. Allianz Asset Management GmbH acquired a new position in USANA Health Sciences in the 2nd quarter valued at $638,000. Envestnet Portfolio Solutions Inc. acquired a new position in USANA Health Sciences in the 2nd quarter valued at $274,000. Pzena Investment Management LLC raised its holdings in USANA Health Sciences by 9.4% in the 2nd quarter. Pzena Investment Management LLC now owns 1,198,260 shares of the company’s stock valued at $36,583,000 after acquiring an additional 103,074 shares during the last quarter. Finally, CWM LLC raised its holdings in USANA Health Sciences by 109.7% in the 2nd quarter. CWM LLC now owns 2,762 shares of the company’s stock valued at $84,000 after acquiring an additional 1,445 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Stock Up 1.2%

USNA stock opened at $20.88 on Monday. The company has a market cap of $381.39 million, a price-to-earnings ratio of 23.72, a PEG ratio of 1.00 and a beta of 0.61. The business has a fifty day simple moving average of $27.87 and a 200-day simple moving average of $28.96. USANA Health Sciences, Inc. has a 52 week low of $18.69 and a 52 week high of $41.83.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Thursday, October 9th. The company reported $0.56 EPS for the quarter. The business had revenue of $200.22 million during the quarter. USANA Health Sciences had a return on equity of 6.96% and a net margin of 1.86%. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Gilbert A. Fuller sold 1,058 shares of the company’s stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider David Mulham Mulham sold 3,515 shares of the company’s stock in a transaction on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the sale, the insider directly owned 9,260 shares of the company’s stock, valued at approximately $280,207.60. This trade represents a 27.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.63% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

USNA has been the subject of several analyst reports. Zacks Research downgraded USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 21st. Wall Street Zen downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of USANA Health Sciences in a report on Friday. Two research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, USANA Health Sciences has a consensus rating of “Reduce” and a consensus price target of $36.00.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.